Functional mitral regurgitation and cardiac resynchronization therapy in the “era” of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?

Cardiac resynchronization therapy (CRT) has been associated to left ventricle (LV) remodelling, reduction of functional mitral regurgitation (FMR) and clinical improvement in patients with heart failure and reduced ejection fraction (HFrEF). The prevalence of significant FMR in patients with LV dyssynchrony that are candidate to CRT is up to 40%. Current approach in patients with FMR undergoing CRT consists of re-evaluation of the amount of FMR following a waiting period of at least 3  months after the implant.

Source: International Journal of Cardiology - March 27, 2020 Category: Cardiology Authors: Mara Gavazzoni, Maurizio Taramasso, Michel Zuber, Alberto Pozzoli, Mizuki Miura, Dinaldo Oliveira, Francesco Maisano Source Type: research